VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 102 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $288,927 | -32.0% | 39,097 | -9.1% | 0.00% | -25.0% |
| Q3 2022 | $425,000 | -24.5% | 43,028 | -16.6% | 0.00% | 0.0% |
| Q2 2022 | $563,000 | +2.0% | 51,595 | +5.7% | 0.00% | +33.3% |
| Q1 2022 | $552,000 | -16.6% | 48,802 | +15.6% | 0.00% | 0.0% |
| Q4 2021 | $662,000 | -28.4% | 42,220 | -21.8% | 0.00% | -50.0% |
| Q3 2021 | $925,000 | +93.1% | 53,979 | +142.2% | 0.01% | +100.0% |
| Q2 2021 | $479,000 | -68.4% | 22,287 | -84.8% | 0.00% | -25.0% |
| Q3 2014 | $1,518,000 | -27.4% | 146,195 | +13.2% | 0.00% | -20.0% |
| Q2 2014 | $2,090,000 | -12.0% | 129,156 | -11.6% | 0.01% | -28.6% |
| Q1 2014 | $2,375,000 | +21.0% | 146,148 | -7.6% | 0.01% | +16.7% |
| Q4 2013 | $1,963,000 | – | 158,174 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |